[1] Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228(4705): 1315-1317.
[2] Bazan J, Całkosiński I, Gamian A. Phage display-a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother, 2012, 8(12): 1817-1828.
[3] Castel G, Chtéoui M, Heyd B, et al. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules, 2011, 16(5): 3499-3518.
[4] Jurisson SS, Lydon JD. Potential technetium small molecule radiopharmaceuticals. Chem Rev, 1999, 99(9): 2205-2207.
[5] Bourguignon MH, Loc'h G, Mazière B. The future of SPECT radioisotopes: technetium-99m or iodine-123?. J Nucl Biol Med, 1994, 38(4): 573-576.
[6] Cutler SJ, Perez KL, Barnhart HX, et al. Observer detection limits for a dedicated SPECT breast imaging system. Phys Med Biol, 2010, 55(7): 1903-1916.
[7] Chen L, Wang Y, Cheng D, et al. Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents. Nucl Med Commun, 2011, 32(10): 920-924.
[8] Rusckowski M, Gupta S, Liu G, et al. Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen. Cancer Biother Radiopharm, 2007, 22(4): 564-572.
[9] Hui X, Han Y, Liang S, et al. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC. J Control Release, 2008, 131(2): 86-93.
[10] 兰晓莉, 高再荣, 孙琳, 等.核素标记血管多肽显像诊断恶性肿瘤实验研究.肿瘤学杂志, 2008, 14(8): 627-630.
[11] Bakker WH, Krenning EP, Reubi JC, et al. In vivo application of 111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci, 1991, 49(22): 1593-1601.
[12] Anderson CJ, Welch MJ. Radiometal-labeled agents(non-technetium) for diagnostic imaging. Chem Rev, 1999, 99(9): 2219-2234.
[13] Boswell CA, Mundo EE, Zhang C, et al. Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugate. J Nucl Med, 2012, 53(9): 1454-1461.
[14] Zou J, Glinsky VV, Landon LA, et al. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis, 2005, 26(2): 309-318.
[15] Kumar SR, Deutscher SL. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors. J Nucl Med, 2008, 49(5): 796-803.
[16] Hooker SD, Freeman LH, Stewart P. Pet therapy research: a historical review. Holist Nurs Pract, 2002, 16(5): 17-23.
[17] Champion L, Brain E, Giraudet AL, et al. Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management. Cancer, 2011, 117(8): 1621-1629.
[18] Picchio M, Giovannini E, Crivellaro C, et al. Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. Radiother Oncol, 2010, 96(3): 347-350.
[19] SUN L, CHU T, WANG Y, et al. Radiolabeling and biodistribution of a nasopharyngeal carcinoma-targeting peptide identified by in vivo phage display. Acta Biochim Biophys Sin(Shanghai), 2007, 39(8): 624-632.
[20] Zitzmann S, Mier W, Schad A, et al. A new prostate carcinoma binding peptide(DUP-1)for tumor imaging and therapy. Clin Cancer Res, 2005, 11(1): 139-146.
[21] Anthony LB, Woltering EA, Espenan GD, et al. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic maligna-ncies. Semin Nucl Med, 2002, 32(2): 123-132.
[22] Mitra A, Nan A, Papadimitriou JC, et al. Polymer-peptide conjuga-tes for angiogenesis targeted tumor radiotherapy. Nucl Med Biol, 2006, 33(1): 43-52.
[23] Reubi C, Gugger M, Waser B. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging, 2002, 29(7): 855-862.
[24] Paganelli G, Bodei L, Handkiewicz Junak D, et al. 90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. Biopolymers, 2002, 66(6): 393-398.
[25] Zitzmann S, Krämer S, Mier W, et al. Identification and evaluation of a new tumor cell-binding peptide, FROP-1. J Nucl Med, 2007, 48(6): 965-972.